Speaker:  Perry Maliuanag, MD, FAPA

Planner: Priya Venkatesh, MD

Target Audience: 

Psychiatry Physicians 


Objectives:

  • Compare the effect of Lorazepam vs placebo as an adjuvant to Haloperidol for persistent agitationin patients with delirium in setting of advanced cancer.

Disclosure: The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations. The CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products. 


Kaiser Santa Clara is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Kaiser Santa Clara designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Session date: 
Friday, February 8, 2019 - 12:30pm to 1:30pm
Location: 
Tantau Psychiatry
Santa Clara, CA
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 Pain/EOL

Please login or register to take this course.
CME Office: